SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Linda Kaplan who wrote (5667)9/24/1998 11:34:00 AM
From: dino  Read Replies (1) | Respond to of 7041
 
Linda.....are you actually saying you might take a position in this stock (short of course) instead of just sitting in your armchair and barking out negative spins at an average of one post per 30 minutes.

This "we" you keep referring to in your posts must be your multiple personalities or imaginary friends because it certainly does not speak for the sentiment on this board.

I believe sales in Mexico will be down for BOTH Viagra and Vasomax but the quarterly filings will put speculation to rest in October.

Another positive step for Vasomax with a pipeline of drugs lurking in the shadows. Through the remainder of 1998, it will be demonstrated that this is not a one product company.

A good day to all.........



To: Linda Kaplan who wrote (5667)9/24/1998 1:08:00 PM
From: Tokyo VD  Read Replies (1) | Respond to of 7041
 
Linda,

Zonagen has 45 days after the last day of a fiscal quarter to report its results.

Tokyo